Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to sofetabart mipitecan (LY4170156) for the treatment of adult patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have received prior bevacizumab and mirvetuximab soravtansine, if eligible. Sofetabart mipitecan is a […] The post Lilly’s sofetabart mipitecan receives U.S. FDA’s Breakthrough Therapy designation for the treatment of certain patients with platinum-resistant ovarian cancer appeared first on Web-Release.

    Genetec Inc. (“Genetec”), the global leader in enterprise physical security software, announced that it has signed a Memorandum of Understanding (MoU) with Etimad Holding (“Etimad”), part of EDGE Group, to strengthen unified physical security capabilities in the United Arab Emirates. The MoU was formally signed between Firas Jadalla, Regional Director, META at Genetec and Saeed […] The post Genetec and Etimad sign MoU to advance unified physical security innovation in the UAE appeared first on Web-Release.

    Since 2008, Laboratoires Novexpert has redefined skincare by proving consumers no longer have to choose between results and safety. Created by leading French scientists and medical experts, it is the first 100% clean dermo-cosmetic brand, offering clinically tested, non-comedogenic, vegan, allergen-free, and preservative-free formulas that tackle a wide range of skin concerns. Innovation Rooted in […] The post Laboratoires Novexpert: Where Safety Meets Effectiveness in Skincare appeared first on Web-Release.